The ARC Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS) strives to build a critical understanding of peptides and proteins in order to unleash the potential of these biomolecules for human benefit. We will discover nature’s untapped reservoir of peptides and proteins, decode their structures and functions, and develop enhanced synthetic technologies to address biology’s next grand challenge—the design of peptides and proteins for targeted scientific, agricultural, biotechnology, animal health and pharmaceutical applications. CIPPS will assemble leading researchers from diverse disciplines to create a sustainable national entity that will drive new Australian industries and train next generation researchers.

Funding: $35 million over 7 years
Centre Director: Professor David Craik
Administering Organisation: The University of Queensland

Participating Organisations:

  • The University of Sydney
  • The Australian National University
  • Monash University
  • Queensland University of Technology
  • Edith Cowan University
  • CSIRO
  • Commonwealth Scientific and Industrial Research Organisation
  • Innovate AG Pty Ltd
  • Hexima Limited
  • Nexgen Plants Pty Ltd
  • University of Washington, Seattle
  • Massachusetts Institute of Technology
  • University of Tokyo
  • University of Oxford, UK
  • University of Southampton, UK
  • University of Illinois at Urbana-Champaign
  • Bioplatforms Australia Ltd
  • Boston Children’s Hospital
  • AstraZeneca AB 
  • Beta Therapeutics Pty Ltd
  • ALMAC Group
  • Zealand Pharma A/S
  • AB SCIEX Australia Pty Ltd 
  • Novo Nordisk A/S
  • Vapourtec Ltd 
  • Questacon